0001053310-22-000002.txt : 20220511 0001053310-22-000002.hdr.sgml : 20220511 20220511143726 ACCESSION NUMBER: 0001053310-22-000002 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220506 FILED AS OF DATE: 20220511 DATE AS OF CHANGE: 20220511 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KAY E GERALD CENTRAL INDEX KEY: 0001053310 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-31668 FILM NUMBER: 22913222 MAIL ADDRESS: STREET 1: C/O 225 LONG AVENUE CITY: HILLSIDE STATE: NJ ZIP: 07205 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTEGRATED BIOPHARMA INC CENTRAL INDEX KEY: 0001016504 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222407475 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 225 LONG AVENUE STREET 2: BUILDING 15 CITY: HILLSIDE STATE: NJ ZIP: 07205 BUSINESS PHONE: 9739260816 MAIL ADDRESS: STREET 1: 225 LONG AVENUE STREET 2: BUILDING 15 CITY: HILLSIDE STATE: NJ ZIP: 07205 FORMER COMPANY: FORMER CONFORMED NAME: INTEGRATED HEALTH TECHNOLOGIES INC DATE OF NAME CHANGE: 20020912 FORMER COMPANY: FORMER CONFORMED NAME: CHEM INTERNATIONAL INC DATE OF NAME CHANGE: 19960716 4/A 1 primary_doc.xml PRIMARY DOCUMENT X0306 4/A 2022-05-06 2022-05-06 0 0001016504 INTEGRATED BIOPHARMA INC inbp 0001053310 KAY E GERALD C/O 225 LONG AVENUE HILLSIDE NJ 07205 1 1 1 0 Executive Chairman & President Common Stock 2022-05-06 4 M 0 100000 0.23 A 5345889 D Stock Option (right to buy) 0.23 2022-05-06 4 M 0 100000 0 D 2024-05-24 Common Stock 100000 150000 D This Form 4 is being amended to correct the Transaction Code in Table 1 and to include the previously inadvertently omitted disclosure in Table II. 100,000 common stock shares acquired upon exercise of stock option grant dated May 24, 2019. The option vested 50% (125,000) on grant date (May 24, 2019) and in three equal annual installments for the remaining 50% (125,000) beginning on May 24, 2020 and ending May 24, 2022. /s/ E. Gerald Kay 2022-05-11